Literature DB >> 20860993

Estimation of the 2-sample hazard ratio function using a semiparametric model.

Song Yang1, Ross L Prentice.   

Abstract

The hazard ratio provides a natural target for assessing a treatment effect with survival data, with the Cox proportional hazards model providing a widely used special case. In general, the hazard ratio is a function of time and provides a visual display of the temporal pattern of the treatment effect. A variety of nonproportional hazards models have been proposed in the literature. However, available methods for flexibly estimating a possibly time-dependent hazard ratio are limited. Here, we investigate a semiparametric model that allows a wide range of time-varying hazard ratio shapes. Point estimates as well as pointwise confidence intervals and simultaneous confidence bands of the hazard ratio function are established under this model. The average hazard ratio function is also studied to assess the cumulative treatment effect. We illustrate corresponding inference procedures using coronary heart disease data from the Women's Health Initiative estrogen plus progestin clinical trial.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20860993      PMCID: PMC3062151          DOI: 10.1093/biostatistics/kxq061

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  7 in total

1.  Semi-parametric models of long- and short-term survival: an application to the analysis of breast cancer survival in Utah by age and stage.

Authors:  A Tsodikov
Journal:  Stat Med       Date:  2002-03-30       Impact factor: 2.373

2.  Simultaneous inferences on the contrast of two hazard functions with censored observations.

Authors:  Peter B Gilbert; L J Wei; Michael R Kosorok; John D Clemens
Journal:  Biometrics       Date:  2002-12       Impact factor: 2.571

3.  Joint estimation of time-dependent and non-linear effects of continuous covariates on survival.

Authors:  Michal Abrahamowicz; Todd A MacKenzie
Journal:  Stat Med       Date:  2007-01-30       Impact factor: 2.373

4.  The impact of heterogeneity in individual frailty on the dynamics of mortality.

Authors:  J W Vaupel; K G Manton; E Stallard
Journal:  Demography       Date:  1979-08

5.  Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

Authors:  Ross L Prentice; Robert Langer; Marcia L Stefanick; Barbara V Howard; Mary Pettinger; Garnet Anderson; David Barad; J David Curb; Jane Kotchen; Lewis Kuller; Marian Limacher; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2005-07-20       Impact factor: 4.897

6.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

7.  Estrogen plus progestin and the risk of coronary heart disease.

Authors:  JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

  7 in total
  3 in total

1.  Semiparametric inference on the absolute risk reduction and the restricted mean survival difference.

Authors:  Song Yang
Journal:  Lifetime Data Anal       Date:  2013-02-08       Impact factor: 1.588

2.  Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial.

Authors:  Song Yang; Ross L Prentice
Journal:  Stat Med       Date:  2015-02-17       Impact factor: 2.373

3.  A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.

Authors:  Song Yang; Walter T Ambrosius; Lawrence J Fine; Adam P Bress; William C Cushman; Dominic S Raj; Shakaib Rehman; Leonardo Tamariz
Journal:  Clin Trials       Date:  2018-04-19       Impact factor: 2.486

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.